News

Priors provide more power for MammoScreen®

For the first time, an AI-based decision support software for breast cancer detection uses patient’s prior exams to…

AI MammoScreen

The AI Elephant in the Reading Room | learning lab review

There’s a lot of talk around AI for mammography, it certainly cannot be ignored. We organized this learning lab to…

Visit-Therapixel-SBI-2021- MammoScreen

Visit us virtually at SBI/ACR Breast Imaging Symposium 2021

Learn more about the award-winning MammoScreen® AI at the virtual exhibition

THERAPIXEL INC AND EMORY UNIVERSITY DEPARTMENT OF RADIOLOGY & IMAGING SCIENCES BREAST IMAGING DIVISION ANNOUNCE RESEARCH PARTNERSHIP

The aim of this partnership is to evaluate the potential of Therapixel’s MammoScreen™ , an AI-based aid for reading…

CE Marking

Therapixel receives the CE mark for its Artificial Intelligence-based software (AI) MammoScreen™

This cutting-edge technology assists radiologists in the interpretation of screening mammograms and allows them to…

MammoScreen at RSNA 2020

MammoScreen at the RSNA 2020 annual meeting – Virtual Radiology Conference

Visit our digital booth to learn more about MammoScreen™, an AI proficiency tool

Partnership

Therapixel and RAD-AID International Announce Breast Imaging AI Collaboration for Global Health

The collaboration donates and supports AI for making breast cancer screening more accessible and available in…

ISO27001

Operations for MammoScreen by Therapixel are now ISO/IEC 27001 certified

Our information security management system is compliant with the world gold standard, ensuring a high level of…

MammoScreen is FDA-Cleared

MammoScreen is FDA-cleared and available for sale in the US

AI-powered reading aid for screening mammography improves Radiologists’ performance in cancer detection